SHR-2004 injection

DRUG3 trials

Sponsors

Beijing Suncadia Pharmaceuticals Co., Ltd

Conditions

Atrial FibrillationPrevention of Arterial and Venous ThrombosisPrevention of Venous Thromboembolism After Knee Arthroplasty

Phase 1

Study on the Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of SHR-2004 Injection in Adult Patients With Atrial Fibrillation

CompletedNCT06280768

Beijing Suncadia Pharmaceuticals Co., LtdAtrial Fibrillation

Start: 2024-04-10End: 2025-01-10Updated: 2026-08-10

Phase 2

SHR-2004 for the Prevention of Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty

CompletedNCT05752461

Beijing Suncadia Pharmaceuticals Co., LtdPrevention of Venous Thromboembolism After Knee Arthroplasty

Start: 2023-04-12End: 2024-06-25Updated: 2025-01-20

Phase 3

A Clinical Study of SHR-2004 Injection in Preventing Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty

CompletedNCT06825416

Beijing Suncadia Pharmaceuticals Co., LtdPrevention of Arterial and Venous Thrombosis

Start: 2025-03-16End: 2026-04-23Updated: 2026-08-28